학술논문
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial
Document Type
Article
Author
Source
In Annals of Oncology August 2016 27(8):1625-1632
Subject
Language
ISSN
0923-7534